SVI | Stage I | Stage II | Stage III | Stage IV | ||||
---|---|---|---|---|---|---|---|---|
OR (95% CI) | P-Value | OR (95% CI) | P-Value | OR (95% CI) | P-Value | OR (95% CI) | P-Value | |
Overall SVI | 0.98 (0.94–1.01) | 0.18 | 1.04 (1.00-1.08) | 0.04* | 1.11 (1.06–1.16) | < 0.001* | 1.15 (1.09–1.21) | < 0.001* |
Q1 | Reference | |||||||
Q2 | 0.93 (0.73–1.19) | 0.57 | 1.00 (0.77–1.31) | 0.99 | 1.17 (0.80–1.71) | 0.43 | 1.30 (0.86–1.96) | 0.22 |
Q3 | 0.83 (0.63–1.10) | 0.20 | 1.12 (0.84–1.50) | 0.44 | 1.58 (1.06–2.36) | 0.03* | 1.85 (1.21–2.82) | < 0.01* |
Q4 | 0.96 (0.71–1.30) | 0.78 | 1.48 (1.08–2.02) | 0.02* | 2.43 (1.62-3.66) | < 0.001* | 3.33 (2.19–5.05) | < 0.001* |